Tilmacoxib
From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
| Pharmacokinetic data | |
|---|---|
| Bioavailability | solution (64–88%) compared with capsule (22–40%). |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H19FN2O3S |
| Molar mass | 338.40 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Tilmacoxib or JTE-522 is a COX-2 inhibitor and is an effective chemopreventive agent against rat experimental liver fibrosis.[1]
See also
[edit ]References
[edit ]- ^ Yamamoto H, Kondo M, Nakamori S, Nagano H, Wakasa K, Sugita Y, et al. (August 2003). "JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1". Gastroenterology. 125 (2): 556–71. doi:10.1016/s0016-5085(03)00904-1 . PMID 12891558.
Stub icon
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.